Clinical operations note: how-to-vet-a-medical-device-company-in-2025-a-buyer039s-checklist-154

When I took over purchasing for a multi-specialty clinic and its affiliated surgery center in early 2020, I inherited a vendor system built from memory. Quotes lived in inboxes, paper files lived in a drawer, and no one could say exactly why we bought from certain suppliers other than habit. My first large equipment order looked fine on price and painful afterward, once freight, installation, and a first-year service contract appeared on the invoice. After that, I built a seven-step vetting checklist and I now run every vendor through it, from implant manufacturers to routine consumables suppliers. If you buy medical devices for a hospital, clinic, or surgery center, this is the checklist I wish my predecessor had left me.

1. Pull a company profile based on records, not the brochure

A polished about-us page is not a company profile. Start with the FDA Establishment Registration and Device Listing database at accessdata.fda.gov to confirm the company is registered and its listed devices match your planned use. If the vendor is publicly traded, pull the latest 10-K from SEC EDGAR at sec.gov/edgar. If it is a private company, ask for audited financials or a Dun and Bradstreet report, and note which companies decline to provide one.

When I pulled the Globus Medical company profile in March 2024 before a spine system evaluation, the SEC filing was more useful than the sales deck. It showed the company files under NYSE: GMED, operates its own manufacturing facilities, and had absorbed NuVasive through a merger completed in 2023. That merger detail matters in a purchasing file because regulatory listings and existing contract terms go through transitions. (I last checked the FDA listing status in January 2025; do your own verification when you run the search.)

2. Verify the device class and exact clearance number

A compliance letter with a letterhead is not verification. Every medical device falls into a class, and every clearance number corresponds to a product code. I only believed this after ignoring it: in 2023 we evaluated a refurbished hematology analyzer from a distributor that sent a clean-looking regulatory letter. It took three weeks for the lab director to notice that the 510(k) referenced a product code that did not match the model quoted. We canceled the deal, but the lost time annoyed an entire department. Now I pull the clearance number before the first sales call.

The distinction matters by risk level. A routine incontinence product may be Class I exempt, or it may not be regulated as a medical device at all, depending on what the label claims. A mid-risk product such as a hematology analyzer requires an active 510(k) for the specific model, not just for the company. A high-risk device such as a vagus nerve stimulator requires a Premarket Approval, not a 510(k), because it is a Class III device. Ask the vendor to send the actual clearance letter with the product code and model name, then check it against the FDA product classification database. If the vendor hesitates, you have already learned something valuable.

3. Calculate the total delivered cost line by line

List price is not the price. In my first year, I made the classic rookie error of asking three vendors for a price list and choosing the middle quote. The middle vendor later added freight, installation, calibration standards, and a mandatory first-year service contract. The final total was higher than the expensive vendor's complete offer (which, honestly, taught me more than any purchasing course did). Now I do not compare suppliers until I have a line-item quote covering the device, delivery, installation, initial training, consumables, service contract, and expected software updates over the first two years.

4. Bring the people who support the product into the evaluation

The clinician can love a device, but the staff who reprocess, maintain, and schedule it will determine whether it actually works in your building. When our orthopedic team evaluated Globus Medical's ExcelsiusGPS navigation system in 2024, the best question came from an instrument technician, not from a surgeon: how many instrument trays arrive for each case, and can they be turned around between two procedures in one day? The sales rep had to escalate the question, which was exactly why the technician belonged in the room. For any capital purchase, include at least one clinical user, one person from sterile processing or biomedical engineering, and one person from purchasing. Missing voices show up later as expensive surprises.

5. Ask for references that look like your facility

A reference from a large academic medical center does not tell you much about a community hospital or an ambulatory surgery center. Ask the vendor for two client sites with similar size, case volume, and staffing. When you call, ask to speak with the supply chain or materials manager instead of the clinical champion. Two questions matter most: how many unplanned service calls were logged in the first year, and how long did the vendor take to respond? Written references get negotiated and polished; a phone conversation is harder to spin.

6. Verify reimbursement support before you sign

For diagnostics, imaging, implants, and surgical capital equipment, reimbursement determines whether a purchase actually makes sense. A vendor should be able to produce current coding documents, relevant coverage policies, or access to a reimbursement specialist who answers questions in writing. When we reviewed Globus Medical's portfolio for spinal implants, its regulatory affairs and reimbursement team supplied the relevant coding and coverage documentation for the products under evaluation. Expect that level of support from any serious supplier. If a vendor cannot explain how its product is billed, the question simply moves from the pre-purchase phase to the post-case phase, where the answer costs much more. Medicare payment rates update every year, so use the January 2025 CMS files when you verify.

7. Put every after-sale promise into the signed contract

The slide deck says training and implementation support are included. The contract says nothing. That exact gap cost us $2,800 in 2023 when a different supplier changed account managers and the new manager had no record of the training promise. Now I treat sales presentations as suggestions until they appear in the signature document. My minimum contract checklist includes response time for service calls, spare parts availability, software updates, training hours, and a cap on consumable price increases for at least two years.

What still goes wrong after the checklist

Even with this process, four mistakes keep showing up.

• Comparing sticker prices while ignoring consumables. A lower upfront quote can disappear under the cost of proprietary consumables over five years. I build a simple five-year cost projection before approving any capital request.
• Treating every order as if it needs three quotes. A full bidding process has transaction costs. For commodity items with reliable current suppliers, the three-quote rule wastes time. We reserve it for new categories, high-dollar purchases, or contracts above a meaningful annual threshold.
• Forgetting to verify the delivered device. The product that arrives must match the model, firmware level, accessory list, and FDA clearance status that you approved. Model names evolve, and substitutions happen. Check the label and the device listing before it goes into service.
• Underestimating quality's effect on clinical confidence. It is rarely one big failure. It is a poorly designed instrument tray, a software update that never arrives, a disposable item that does not fit. Clinicians interpret these small problems as signals about how much the organization cares about their work, and purchasing takes the blame. Once that confidence is gone, winning it back is much harder than paying a little more upfront would have been.

My rule is simple: do not buy based on a conversation; buy based on documents. If a vendor is unwilling to produce regulatory records, line-item costs, references from comparable facilities, or contract language that matches its promises, that reluctance is information. It will cost less to discover before the purchase order than after delivery.